SCHEMBL8869358

SCHEMBL8869358

COC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2cccc(CCNC(=O)CC3CCCCC3)c2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.43
LMNA P02545 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 2/20 0.40
BLM P54132 2/20 0.40
HTR1A P08908 1/20 0.40
NFKB1 P19838 1/20 0.40
CNR1 P21554 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
P4HTM Q9NXG6 2/20 0.39
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 3/20 0.38
PKM P14618 1/20 0.38
MCL1 Q07820 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868686 0.92 EPHX2 (0.44) EPHX2LMNACYP3A4CYP2C9CYP2C19
SCHEMBL8869748 0.91 LMNA (0.49) EPHX2LMNACYP3A4CYP2C9CYP2C19
SCHEMBL9139947 0.91 EPHX2 (0.46) EPHX2LMNACYP3A4CYP2C9CYP2C19
SCHEMBL8868623 0.90 EPHX2 (0.47) EPHX2LMNACYP3A4CYP2C9CYP2C19
SCHEMBL8867975 0.89 MAPT (0.43) LMNACYP3A4CYP2C9CYP2C19MAPT
SCHEMBL9139607 0.88 P4HTM (0.53) EPHX2LMNACYP3A4CYP2C9CYP2C19
SCHEMBL8868968 0.86 P4HTM (0.47) LMNAMAPTSMN1; SMN2HDAC6P4HTM
SCHEMBL8868114 0.86 P4HTM (0.42) LMNASMN1; SMN2P4HTMALDH1A1HIF1A
SCHEMBL8869629 0.85 P4HTM (0.45) LMNAMAPTSMN1; SMN2P4HTMKMT2A
SCHEMBL8869839 0.85 P4HTM (0.46) LMNAMAPTSMN1; SMN2HDAC6P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed